Lipid Disorders
From the Journals
LDL cholesterol triglycerides ‘robust’ ASCVD risk marker
A large dual-method Danish population study identified high LDL triglyceride levels as a risk marker for atherosclerotic cardiovascular disease....
Feature
Recount of FOURIER data finds higher mortality with evolocumab; trialists push back
A readjudication of mortality data from the FOURIER trial by outside researchers concludes CV death was higher with evolocumab than originally...
News
FDA approves Wegovy (semaglutide) for obesity in teens 12 and up
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.
From the Journals
Top cardiology societies call for revamp of clinical trials
Clinical trials have become too costly and burdensome, and it’s time to reinvent how they are conducted, leading cardiology societies say in a...
From the Journals
High lipoprotein(a) levels plus hypertension add to CVD risk
A new analysis illustrates, for the first time, a significant interaction between Lp(a) and hypertension in the primary prevention of...
Feature
‘The Whale’: Is this new movie fat-phobic or fat-friendly?
Brendan Fraser wears prosthetics to portray a 600-lb man in “The Whale,” sparking controversy from activists around the casting decision.
From the Journals
The 'Plaque Hypothesis': Focus on vulnerable lesions to cut events
A new strategy is needed that targets unstable plaque in the whole of the coronary arteries, rather than just obstructive lesions, to reduce major...
Guidelines
New AHA statement on managing ACS in older adults
Aging may alter the diagnosis and treatment of acute coronary syndrome in older adults, the American Heart Association notes in a new scientific...
Guidelines
ADA issues 2023 ‘Standards of Care’ for diabetes: Focus on tight BP, lipids
The new 2023 American Diabetes Association Standards of Care address management of diabetes and its complications, as well as social determinants...
Feature
Bempedoic acid cuts CV risk in the statin-intolerant: CLEAR top-line results
In top-line results, high-risk patients with statin intolerance taking the lipid-lowering agent showed a significant decline in risk for CV events...
From the Journals
Statins tied to lower ICH risk regardless of bleed location
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance...